These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20576207)

  • 1. What can we learn from negative clinical trials in systemic sclerosis?
    Veale DJ
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S1-4. PubMed ID: 20576207
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous HSCT in systemic sclerosis: a step forward.
    Farge D; Gluckman E
    Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?].
    Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D
    Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational data to study medication outcomes in systemic sclerosis.
    Hudson M; Baron M; ; Steele R
    J Rheumatol; 2011 Mar; 38(3):575-7. PubMed ID: 21362793
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel treatment approaches to fibrosis in scleroderma.
    Distler J; Distler O
    Rheum Dis Clin North Am; 2008 Feb; 34(1):145-59; vii. PubMed ID: 18329537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide in systemic sclerosis: light and shadows.
    Vlachoyiannopoulos PG; Ioannidis JP
    Clin Exp Rheumatol; 2004; 22(5):551-2. PubMed ID: 15485005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
    Siegert E; Riemekasten G
    Rheumatology (Oxford); 2016 Oct; 55(10):1914-6. PubMed ID: 27330162
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of diucifon in rheumatoid arthritis and systemic scleroderma].
    Abdrakhmanova RSh; Bilich IL; Mangusheva MM; Bombina LK; Khalfieva GM
    Ter Arkh; 1986; 58(7):101-3. PubMed ID: 3532398
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
    Simms RW; Lafyatis R
    Rheumatology (Oxford); 2010 Feb; 49(2):201-2. PubMed ID: 20032221
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 14. Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
    Boin F; Wigley F
    Nat Rev Rheumatol; 2009 Jul; 5(7):357-8. PubMed ID: 19568247
    [No Abstract]   [Full Text] [Related]  

  • 15. [Systemic sclerosis].
    Villiger PM
    Ther Umsch; 2008 May; 65(5):283-7. PubMed ID: 18622933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EF/SSc overlap syndrome and aplastic anaemia resistant to immunosuppressive therapy.
    De Masson A; Bouaziz JD; Rybojad M; Peffault de Latour R; Robin M; Rodriguez-Otero P; Durant C; Socié G; Bagot M
    Rheumatology (Oxford); 2012 Apr; 51(4):762-4. PubMed ID: 22223703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of scleroderma].
    Guillevin L; Ortonne JP
    Ann Med Interne (Paris); 1983; 134(8):754-65. PubMed ID: 6364917
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral tacrolimus for the treatment of generalized morphea.
    Hirohata A; Hanafusa T; Igawa K; Inoue-Nishimoto T; Mabuchi-Kiyohara E; Nishide M; Yokozeki H; Ikegami R
    Eur J Dermatol; 2016; 26(1):112-3. PubMed ID: 26679400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of scleroderma].
    Mouthon L
    Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.